CME Group (CME)
(Delayed Data from NSDQ)
$222.04 USD
+0.87 (0.39%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $222.04 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$222.04 USD
+0.87 (0.39%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $222.04 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Zacks News
Reasons Why CME Group (CME) Stock is an Attractive Pick
by Zacks Equity Research
CME Group (CME) stands to gain from market data distribution channels, higher custody fees and prudent capital deployment.
Will CME (CME) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cboe Global (CBOE) Up 16.5% in a Year: Will the Rally Last?
by Zacks Equity Research
Cboe Global (CBOE) stock rallies on the back of strong market position, global reach, higher logical port fees and physical port fees, favorable growth estimates and solid capital position.
What Makes CME (CME) a New Buy Stock
by Zacks Equity Research
CME (CME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Top Analyst Reports for Chevron, Coca-Cola & General Electric
by Santanu Roy
Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), The Coca-Cola Company (KO) and General Electric Company (GE).
Why Is CME (CME) Down 3% Since Last Earnings Report?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Hold is an Apt Strategy for CME Group (CME) Stock
by Zacks Equity Research
CME Group (CME) is poised to grow, given its market data distribution channels, higher custody fees and prudent capital deployment.
Zacks Industry Outlook Highlights CME Group, Cboe Global Markets, Nasdaq, MarketAxess Holdings and Coinbase Global
by Zacks Equity Research
CME Group, Cboe Global Markets, Nasdaq, MarketAxess Holdings and Coinbase Global are part of the Zacks Industry Outlook article.
5 Stocks to Watch From the Prospering Securities and Exchanges Industry
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CME, CBOE, NDAQ, MKTX and COIN. However, compliance with regulations remains a challenge.
CME Group (CME) Q4 Earnings Top on Higher Trading Volume
by Zacks Equity Research
CME Group (CME) Q4 results reflect higher revenues, driven by increased trading volume.
CME Group (CME) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 1.05% and 0.23%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Will CME Group (CME) Keep Its Beat Streak Alive in Q4 Earnings?
by Zacks Equity Research
CME Group's (CME) Q4 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.
CBOE Global (CBOE) Q4 Earnings Top Estimates
by Zacks Equity Research
CBOE (CBOE) delivered earnings and revenue surprises of 1.69% and 0.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Awaits Intercontinental (ICE) This Earnings Season?
by Zacks Equity Research
Intercontinental's (ICE) fourth-quarter results are likely to reflect solid performance at Exchanges and Fixed Income and Data Services segments.
What's in the Cards for Cboe Global (CBOE) in Q4 Earnings?
by Zacks Equity Research
Cboe Global's (CBOE) fourth-quarter results are likely to reflect higher volumes across businesses, higher logical port fees, and contribution from acquisitions as well as from strong proprietary products.
Nasdaq's (NDAQ) Q4 Earnings Miss, Revenues Increase Y/Y
by Zacks Equity Research
Nasdaq's (NDAQ) Q4 results reflect solid performance in both Solutions Businesses and Trading Services segments.
Will CME (CME) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights Booking Holdings, U.S. Bancorp, CME Group, Consolidated Edison and Diamondback Energy
by Zacks Equity Research
Booking Holdings, U.S. Bancorp, CME Group, Consolidated Edison and Diamondback Energy are part of the Zacks top Analyst Blog.
Top Analyst Reports for Booking Holdings, U.S. Bancorp & CME Group
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Booking Holdings Inc. (BKNG), U.S. Bancorp (USB) and CME Group Inc. (CME).
Why Should You Stay Invested in CME Group (CME) Stock Now?
by Zacks Equity Research
CME Group's (CME) global presence, compelling product portfolio, and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
Are Options Traders Betting on a Big Move in CME Group (CME) Stock?
by Zacks Equity Research
Investors need to pay close attention to CME Group (CME) stock based on the movements in the options market lately.
The Zacks Analyst Blog Highlights Analog Devices, The Southern Company, Canadian Pacific Railway, CME Group and UBS
by Zacks Equity Research
Analog Devices, The Southern Company, Canadian Pacific Railway, CME Group and UBS are included in this Analyst Blog.
Top Stock Reports for Analog Devices, Southern Company & Canadian Pacific Railway
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Analog Devices, Inc. (ADI), Southern Company (SO) and Canadian Pacific Railway Limited (CP).